Apheresis Equipment Market By Procedure (Plasmapheresis, LDL-Apheresis, Plateletpheresis, Leukapheresis, Photophereis, Erythrocytapheresis), By Products & Technology (Apheresis Devices, Disposable Kits, Membrane Filtration, Centrifugation), By Applications (Renal, Neurology, Hematology) - Growth, Future Prospects And Competitive Analysis, 2016 - 2023

Rising incidence of hematological disorders has led to growth in demand for platelets and plasma products for efficient treatment and improvement in survival rates. The apheresis equipment market is expected to be driven by growth in incidence of blood disorders and technological innovations in nature and efficiency of apheresis equipment. Researchers, healthcare practitioners and device manufacturers worldwide are hence introducing solutions that demand minimum human intervention and allow agility to apheresis process.

For the purpose of this study, the global apheresis equipment market studied for product type, application, technology, procedure type and geographical distribution. Based on product types, this market is categorized into apheresis device and disposable kits segments. Membrane filtration and centrifugation are the two technologies adopted for performing apheresis. Apheresis finds major adoption in renal, neurology, hematology and other such applications. Based on procedure types, the global apheresis market is segmented into major procedures, namely, plasmapheresis, LDL-apheresis, plateletpheresis, leukapheresis, photophereis, erythrocytapheresis and others. Market size and forecast for each such mentioned segment for the period 2013-2023 along with respective  CAGR for the period 2016-2023 are provided in this study, while analyzing the major market developments, commercial events, product positioning and movements by market players.

Geographically, the global apheresis equipment market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Middle East and Africa
  • Latin America

Market size and forecast for these regional and country level markets are presented in this study for the period 2013-2023. Market growth rates for the forecast period 2016-2023 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global apheresis equipment market. Tools such as market positioning of key players, Porter’s five forces analysis and attractive investment proposition provide the readers with insights on the competitive scenario of the global apheresis equipment market. This report concludes with company profiles section that highlights major information about the key players engaged in development, manufacture and sales of apheresis equipment market.

Apheresis Equipment Market

Apheresis procedures find major application in hematology, renal, neurology and other treatment areas.

Apheresis Equipment Market

Neurology is the largest segment for apheresis equipment. Increasing prevalence of neurological diseases such as myasthenia gravis and multiple sclerosis is a chief factor contributing to the dominance of this segment. Perpetual widening application of apheresis and growth in R&D efforts aimed at introducing novel products in the market will further boost the market growth. Therapeutic plasma exchange is a crucial treatment for treating myasthenia gravis, Guillain-Barre syndrome, multiple sclerosis or chronic inflammatory demyelinating polyneuropathy. Increasing prevalence of such diseases and proven efficiency of apheresis in treating such conditions is a major driver of this application segment. The burden of sickle cell disease is phenomenally high. Red blood cell transfusion is used as an ideal treatment for sickle cell disease, which is a sub-type of therapeutic hemapheresis. Therapeutic plasma exchange, leukapheresis, photopheresis, plateletpheresis are also becoming popular for treating hematological diseases.

For the purpose of this study, the global apheresis equipment market is categorized as follows:

  • North America (U.S. & Canada)
  • Europe (Germany, U.K. & Rest of Europe)
  • Asia Pacific (Japan, China & Rest of Asia Pacific)
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Apheresis Equipment Market

North America holds over 45% of the global apheresis equipment market in 2015. Well-developed healthcare infrastructure, high awareness between both patients and care-givers and favorable reimbursement are the key drivers of this market. Centrifugation apheresis technology is anticipated to be in high demand in North America market during the forecast period. Increasing incidence of hematological and neurological disorders in Europe that demand apheresis procedure for treatment will drive the European apheresis equipment market. Additionally, Asia Pacific is anticipated to be the fastest progressing market for apheresis equipment during the forecast period. Increasing prevalence of blood disorders that demand treatment with platelets and plasma products in emerging markets of China, Japan, Australia, Korea and India is a key market driver of Asia Pacific market. Rapid development of healthcare infrastructure, and improving awareness in the general population will additionally contribute to demand for apheresis and hence apheresis equipment in the region.

Choose License Type
Published Date:  Aug 2016
Category:  Medical Devices
Report ID:   58047
Report Format:   PDF
Pages:   120
Rating:    4.3 (60)
Connect With Us
24/7 Research Support